{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:46:58Z","timestamp":1760784418313,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Joint Federal Committee","award":["01NVF16003"],"award-info":[{"award-number":["01NVF16003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-018-2502-1","type":"journal-article","created":{"date-parts":[[2018,2,19]],"date-time":"2018-02-19T21:07:08Z","timestamp":1519074428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A novel integrated care concept (NICC) versus standard care in the treatment of chronic cardiovascular diseases: protocol for the randomized controlled trial CardioCare MV"],"prefix":"10.1186","volume":"19","author":[{"given":"Christian","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alper","family":"\u00d6ner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Krockenberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Abbondanzieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Brandewiede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Br\u00fcge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gisela","family":"Hostenkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henriette","family":"Neumeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8386-5397","authenticated-orcid":false,"given":"Andreas","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"key":"2502_CR1","unstructured":"Cardiovascular diseases (CVDs): Fact Sheet. Updated May 2017. \nhttp:\/\/www.who.int\/mediacentre\/factsheets\/fs317\/en\/\n\n. Accessed 18 Feb 2018."},{"key":"2502_CR2","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/S0828-282X(09)70098-4","volume":"25","author":"JE Tarride","year":"2009","unstructured":"Tarride JE, Lim M, DesMeules M, Luo W, Burke N, O\u2019Reilly D, Bowen J, Goeree R. A review of the cost of cardiovascular disease. Can J Cardiol. 2009;25:e195\u2013202.","journal-title":"Can J Cardiol"},{"key":"2502_CR3","unstructured":"Gesundheit in Deutschland. Gesundheitsberichterstattung des Bundes. Gemeinsam getragen von RKI und Destatis. \nhttps:\/\/www.rki.de\/DE\/Content\/Gesundheitsmonitoring\/Gesundheitsberichterstattung\/GesInDtld\/gesundheit_in_deutschland_2015.html\n\n. Accessed 18 Feb 2018."},{"key":"2502_CR4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/01.CIR.95.4.1085","volume":"95","author":"NH Miller","year":"1997","unstructured":"Miller NH, Hill M, Kottke T, Ockene IS. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997;95:1085\u201390.","journal-title":"Circulation"},{"key":"2502_CR5","first-page":"384","volume-title":"Handw\u00f6rterbuch des politischen Systems der Bundesrepublik Deutschland","author":"N Werz","year":"2013","unstructured":"Werz N. Land Mecklenburg-Vorpommern. In: Andersen U, Woyke W, editors. Handw\u00f6rterbuch des politischen Systems der Bundesrepublik Deutschland. 7th ed. Heidelberg: Springer; 2013. p. 384\u201390.","edition":"7"},{"key":"2502_CR6","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00392-014-0799-7","volume":"104","author":"T Meinertz","year":"2015","unstructured":"Meinertz T, Diegeler A, Stiller B, Fleck E, Heinemann MK, Schmaltz AA, Vestweber M, Bestehorn K, Beckmann A, Hamm C, Cremer J. German Heart Report 2013. Clin Res Cardiol. 2015;104:112\u201323.","journal-title":"Clin Res Cardiol"},{"key":"2502_CR7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.113.005119","volume":"129","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129:837\u201347.","journal-title":"Circulation"},{"key":"2502_CR8","first-page":"361","volume":"56","author":"A Schuchert","year":"2005","unstructured":"Schuchert A, Gerth A, N\u00e4bauer M, Steinbeck G, Meinertz T. Vorhofflimmern: Epidemiologie, Klinik und Prognose [Atrial fibrillation: epidemiology, clinic and prognosis]. Med Welt. 2005;56:361\u20135.","journal-title":"Med Welt"},{"key":"2502_CR9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1524-4733.2008.00416.x","volume":"12","author":"D McBride","year":"2009","unstructured":"McBride D, Mattenklotz AM, Willich SN, Br\u00fcggenj\u00fcrgen B. The costs of care in atrial fibrillation and the effect of treatment modalities in Germany. Value Health. 2009;12:293\u2013301.","journal-title":"Value Health"},{"key":"2502_CR10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1185\/030079906X167462","volume":"23","author":"MJ Taylor","year":"2007","unstructured":"Taylor MJ, Scuffham PA, McCollam PL, Newby DE. Acute coronary syndromes in Europe: 1-year costs and outcomes. Curr Med Res Opin. 2007;23:495\u2013503.","journal-title":"Curr Med Res Opin"},{"key":"2502_CR11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/hrt.2002.008748","volume":"90","author":"S Stewart","year":"2004","unstructured":"Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ. Cost of an emerging epidemic: an economic analysis of atrial fibrillation in the UK. Heart. 2004;90:286\u201392.","journal-title":"Heart"},{"key":"2502_CR12","first-page":"269","volume":"106","author":"T Neumann","year":"2009","unstructured":"Neumann T, Biermann J, Erbel R, Neumann A, Wasem J, Ertl G, Dietz R. Heart failure: the commonest reason for hospital admission in Germany: medical and economic perspectives. Dtsch Arztebl Int. 2009;106:269\u201375.","journal-title":"Dtsch Arztebl Int"},{"key":"2502_CR13","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1161\/HYPERTENSIONAHA.111.171520","volume":"57","author":"MI Ahmed","year":"2011","unstructured":"Ahmed MI, Calhoun DA. Resistant hypertension: bad and getting worse. Hypertension. 2011;57:1045\u20136.","journal-title":"Hypertension"},{"key":"2502_CR14","unstructured":"McKelvie RS. Heart failure. BMJ Clin Evid. 2010;2010"},{"key":"2502_CR15","first-page":"810","volume":"44","author":"FA McAlister","year":"2004","unstructured":"McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004;44:810\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"2502_CR16","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1136\/hrt.2004.048389","volume":"91","author":"R Holland","year":"2005","unstructured":"Holland R, Battersby J, Harvey I, Lenaghan E, Smith J, Hay L. Systematic review of multidisciplinary interventions in heart failure. Heart. 2005;91:899\u2013906.","journal-title":"Heart"},{"key":"2502_CR17","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1056\/NEJMsa0902321","volume":"363","author":"DE Wennberg","year":"2010","unstructured":"Wennberg DE, Marr A, Lang L, O\u2019Malley S, Bennett G. A randomized trial of a telephone care-management strategy. N Engl J Med. 2010;363:1245\u201355.","journal-title":"N Engl J Med"},{"key":"2502_CR18","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2261-6-43","volume":"6","author":"A Jovicic","year":"2006","unstructured":"Jovicic A, Holroyd-Leduc JM, Straus SE. Effects of self-management intervention on health outcomes of patients with heart failure: a systematic review of randomized controlled trials. BMC Cardiovasc Disord. 2006;6:43.","journal-title":"BMC Cardiovasc Disord"},{"key":"2502_CR19","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1161\/CIRCULATIONAHA.110.940262","volume":"122","author":"DS Lee","year":"2010","unstructured":"Lee DS, Stukel TA, Austin PC, Alter DA, Schull MJ, You JJ, Chong A, Henry D, Tu JV. Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department. Circulation. 2010;122:1806\u201314.","journal-title":"Circulation"},{"key":"2502_CR20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1067\/mhj.2003.54","volume":"145","author":"OS Indridason","year":"2003","unstructured":"Indridason OS, Coffman CJ, Oddone EZ. Is specialty care associated with improved survival of patients with congestive heart failure? Am Heart J. 2003;145:300\u20139.","journal-title":"Am Heart J"},{"issue":"Suppl 1","key":"2502_CR21","doi-asserted-by":"crossref","first-page":"i35","DOI":"10.1093\/europace\/eut114","volume":"15","author":"RP Ricci","year":"2013","unstructured":"Ricci RP. Disease management: atrial fibrillation and home monitoring. Europace. 2013;15(Suppl 1):i35\u20139.","journal-title":"Europace"},{"key":"2502_CR22","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/eurheartj\/ehr419","volume":"33","author":"P Mabo","year":"2012","unstructured":"Mabo P, Victor F, Bazin P, Ahres S, Babuty D, Da Costa A, Binet D, Daubert JC, Compas Trial Investigators. A randomized trial of long-term remote monitoring of pacemaker recipients (the COMPAS trial). Eur Heart J. 2012;33:1105\u201311.","journal-title":"Eur Heart J"},{"key":"2502_CR23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/jhh.2014.73","volume":"29","author":"DJ Hyman","year":"2015","unstructured":"Hyman DJ, Pavlik V. Medication adherence and resistant hypertension. J Hum Hypertens. 2015;29:213\u20138.","journal-title":"J Hum Hypertens"},{"key":"2502_CR24","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/HYPERTENSIONAHA.116.08818","volume":"69","author":"RL de Jager","year":"2017","unstructured":"de Jager RL, de Beus E, Beeftink MM, Sanders MF, Vonken EJ, Voskuil M, van Maarseveen EM, Bots ML, Blankestijn PJ. Investigators Study. Impact of medication adherence on the effect of renal denervation: the SYMPATHY trial. Hypertension. 2017;69:678\u201384.","journal-title":"Hypertension"},{"key":"2502_CR25","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/ajh.2011.100","volume":"24","author":"S Omboni","year":"2011","unstructured":"Omboni S, Guarda A. Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies. Am J Hypertens. 2011;24:989\u201398.","journal-title":"Am J Hypertens"},{"key":"2502_CR26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/HJH.0b013e32835ca8dd","volume":"31","author":"S Omboni","year":"2013","unstructured":"Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31:455\u201367. discussion 467\u2013458","journal-title":"J Hypertens"},{"key":"2502_CR27","doi-asserted-by":"crossref","first-page":"15071","DOI":"10.1038\/npjpcrm.2015.71","volume":"25","author":"MR Boland","year":"2015","unstructured":"Boland MR, Kruis AL, Huygens SA, Tsiachristas A, Assendelft WJ, Gussekloo J, Blom CM, Chavannes NH, Rutten-van Molken MP. Exploring the variation in implementation of a COPD disease management programme and its impact on health outcomes: a post hoc analysis of the RECODE cluster randomised trial. NPJ Prim Care Respir Med. 2015;25:15071.","journal-title":"NPJ Prim Care Respir Med"},{"key":"2502_CR28","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.288.15.1909","volume":"288","author":"T Bodenheimer","year":"2002","unstructured":"Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness: the chronic care model, Part 2. JAMA. 2002;288:1909\u201314.","journal-title":"JAMA"},{"key":"2502_CR29","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1475-6773.2005.00397.x","volume":"40","author":"ML Pearson","year":"2005","unstructured":"Pearson ML, Wu S, Schaefer J, Bonomi AE, Shortell SM, Mendel PJ, Marsteller JA, Louis TA, Rosen M, Keeler EB. Assessing the implementation of the chronic care model in quality improvement collaboratives. Health Serv Res. 2005;40:978\u201396.","journal-title":"Health Serv Res"},{"issue":"Suppl 2","key":"2502_CR30","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1513\/AnnalsATS.201308-259RM","volume":"11","author":"H Pinnock","year":"2014","unstructured":"Pinnock H, Epiphaniou E, Taylor SJ, Phase IV \u2013 implementation studies. The forgotten finale to the complex intervention methodology framework. Ann Am Thorac Soc. 2014;11(Suppl 2):S118\u201322.","journal-title":"Ann Am Thorac Soc"},{"key":"2502_CR31","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","volume":"158","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Altman DG, Laupacis A, G\u00f8tzsche PC, Krle\u017ea-Jeri\u0107 K, Hr\u00f3bjartsson AA, Mann H, Dickersin K, Berlin JA, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200\u20137.","journal-title":"Ann Intern Med"},{"key":"2502_CR32","doi-asserted-by":"crossref","first-page":"e1000251","DOI":"10.1371\/journal.pmed.1000251","volume":"7","author":"KF Schulz","year":"2010","unstructured":"Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomised Trials. PLoS Med. 2010;7:e1000251.","journal-title":"PLoS Med"},{"key":"2502_CR33","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(07)61835-2","volume":"371","author":"S Hopewell","year":"2008","unstructured":"Hopewell S, Clarke M, Moher D, Wager E, Middleton P, Altman DG, Schulz KF. CONSORT for reporting randomised trials in journal and conference abstracts. Lancet. 2008;371:281\u20133.","journal-title":"Lancet"},{"issue":"37","key":"2502_CR34","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"2016","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, et al. ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;2016(37):2893\u2013962.","journal-title":"Eur Heart J"},{"issue":"37","key":"2502_CR35","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"2016","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) \u2013 Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;2016(37):2129\u2013200.","journal-title":"Eur Heart J"},{"issue":"34","key":"2502_CR36","first-page":"2159","volume":"2013","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, et al. ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;2013(34):2159\u2013219.","journal-title":"Eur Heart J"},{"key":"2502_CR37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","volume":"37","author":"R Brooks","year":"1996","unstructured":"Brooks R. EuroQol: the current state of play. Health Policy. 1996;37:53\u201372.","journal-title":"Health Policy"},{"key":"2502_CR38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40258-017-0310-5","volume":"15","author":"NJ Devlin","year":"2017","unstructured":"Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: past, present and future. Appl Health Econ Health Policy. 2017;15:127\u201337.","journal-title":"Appl Health Econ Health Policy"},{"key":"2502_CR39","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/2047487312450545","volume":"21","author":"N Oldridge","year":"2014","unstructured":"Oldridge N, H\u00f6fer S, McGee H, Conroy R, Doyle F, Saner H. The HeartQoL: part II. Validation of a new core health-related quality of life questionnaire for patients with ischemic heart disease. Eur J Prev Cardiol. 2014;21:98\u2013106.","journal-title":"Eur J Prev Cardiol"},{"key":"2502_CR40","volume-title":"Gesundheitsfragebogen f\u00fcr Patienten (PHQ-D). Komplettversion und Kurzform. Testmappe mit Manual, Frageb\u00f6gen, Schablonen","author":"B L\u00f6we","year":"2002","unstructured":"L\u00f6we B, Spitzer RL, Zipfel S, Herzog W. Gesundheitsfragebogen f\u00fcr Patienten (PHQ-D). Komplettversion und Kurzform. Testmappe mit Manual, Frageb\u00f6gen, Schablonen. 2nd ed. Karlsruhe: Pfizer; 2002.","edition":"2"},{"key":"2502_CR41","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1026\/0012-1924.50.4.171","volume":"50","author":"K Gr\u00e4fe","year":"2004","unstructured":"Gr\u00e4fe K, Zipfel S, Herzog W, L\u00f6we B. Screening psychischer St\u00f6rungen mit dem \u201cGesundheitsfragebogen f\u00fcr Patienten (PHQ-D)\u201d. Diagnostica. 2004;50:171\u201381.","journal-title":"Diagnostica"},{"key":"2502_CR42","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","volume":"46","author":"B L\u00f6we","year":"2008","unstructured":"L\u00f6we B, Decker O, M\u00fcller S, Brahler E, Schellberg D, Herzog W, Herzberg PY. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46:266\u201374.","journal-title":"Med Care"},{"key":"2502_CR43","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000376585","volume":"84","author":"CW Topp","year":"2015","unstructured":"Topp CW, \u00d8stergaard SD, S\u00f8ndergaard S, Bech P. The WHO-5 Well-Being Index: a systematic review of the literature. Psychother Psychosom. 2015;84:167\u201376.","journal-title":"Psychother Psychosom"},{"key":"2502_CR44","first-page":"359","volume":"3","author":"A Ullrich","year":"2010","unstructured":"Ullrich A, Mehnert A. Psychometrische Evaluation and Validierung einer 8-Item-Kurzversion der Skalen zur Sozialen Unterst\u00fctzung bei Krankheit (SSUK) bei Krebspatienten. Klin Diagn Eval. 2010;3:359\u201381.","journal-title":"Klin Diagn Eval"},{"key":"2502_CR45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1186\/1471-2458-13-1027","volume":"13","author":"JM Zill","year":"2013","unstructured":"Zill JM, Dwinger S, Kriston L, Rohenkohl A, Harter M, Dirmaier J. Psychometric evaluation of the German version of the Patient Activation Measure (PAM13). BMC Public Health. 2013;13:1027.","journal-title":"BMC Public Health"},{"key":"2502_CR46","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/mpr.329","volume":"20","author":"MJ Azur","year":"2011","unstructured":"Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psychiatr Res. 2011;20:40\u20139.","journal-title":"Int J Methods Psychiatr Res"},{"key":"2502_CR47","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/sim.4780080705","volume":"8","author":"DR Bristol","year":"1989","unstructured":"Bristol DR. Sample sizes for constructing confidence intervals and testing hypotheses. Stat Med. 1989;8:803\u201311.","journal-title":"Stat Med"},{"key":"2502_CR48","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/ejhf.567","volume":"18","author":"M Christ","year":"2016","unstructured":"Christ M, St\u00f6rk S, D\u00f6rr M, Heppner HJ, M\u00fcller C, Wachter R, Riemer U, Trend HF. Germany Project. Heart failure epidemiology 2000\u20132013: insights from the German Federal Health Monitoring System. Eur J Heart Fail. 2016;18:1009\u201318.","journal-title":"Eur J Heart Fail"},{"key":"2502_CR49","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s00392-015-0841-4","volume":"104","author":"C Ohlmeier","year":"2015","unstructured":"Ohlmeier C, Mikolajczyk R, Frick J, Pr\u00fctz F, Haverkamp W, Garbe E. Incidence, prevalence and 1-year all-cause mortality of heart failure in Germany: a study based on electronic healthcare data of more than six million persons. Clin Res Cardiol. 2015;104:688\u201396.","journal-title":"Clin Res Cardiol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2502-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-018-2502-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-018-2502-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T03:04:14Z","timestamp":1580526254000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-018-2502-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2502"],"URL":"https:\/\/doi.org\/10.1186\/s13063-018-2502-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"type":"electronic","value":"1745-6215"}],"subject":[],"published":{"date-parts":[[2018,2,20]]},"assertion":[{"value":"6 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval was obtained from the Ethics Committee of the Medical Faculty of the University of Rostock on 18 July 2017, and its registration number is A 2017\u20130117.Written informed consent for trial participation will be obtained from all patients prior to randomization.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Armin Br\u00fcge is an employee of Philips Medizin Systeme B\u00f6blingen GmbH. Drs. Henriette Neumeyer and Gisela Hostenkamp are employees of Philips GmbH Market DACH. Dr. Katja Krockenberger is an employee of AMEDON GmbH, and Bernard Brandewiede is CEO of AMEDON GmbH. All other authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"120"}}